Verve Therapeutics Inc (VERV)
4.595
+0.04
(+0.99%)
USD |
NASDAQ |
Nov 21, 16:00
4.595
0.00 (0.00%)
After-Hours: 20:00
Verve Therapeutics Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2022
--
Maximum
Sep 2022
--
Average
--
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| Ardelyx Inc | 0.6362 |
| Biomarin Pharmaceutical Inc | 0.1098 |
| Sage Therapeutics Inc | 0.00 |
| ALX Oncology Holdings Inc | -- |
| Immuneering Corp | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 663.91M |
| Total Liabilities (Quarterly) | 155.36M |
| Shareholders Equity (Quarterly) | 508.55M |
| Current Ratio | 13.05 |